Welch & Forbes’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$609K Sell
9,517
-969
-9% -$63.7K 0.01% 268
2026
Q1
$746K Buy
10,486
+126
+1% +$9.94K 0.01% 243
2025
Q4
$850K Sell
10,360
-287
-3% -$22.4K 0.01% 236
2025
Q3
$800K Sell
10,647
-65
-0.6% -$4.85K 0.01% 243
2025
Q2
$793K Buy
10,712
+1,175
+12% +$81.8K 0.01% 242
2025
Q1
$770K Buy
9,537
+515
+6% +$44.3K 0.01% 240
2024
Q4
$705K Sell
9,022
-669
-7% -$56.9K 0.01% 252
2024
Q3
$910K Sell
9,691
-416
-4% -$34.9K 0.01% 235
2024
Q2
$777K Sell
10,107
-71
-0.7% -$5.79K 0.01% 245
2024
Q1
$925K Sell
10,178
-380
-4% -$31.6K 0.01% 231
2023
Q4
$816K Sell
10,558
-200
-2% -$14K 0.01% 240
2023
Q3
$732K Sell
10,758
-1,653
-13% -$120K 0.01% 243
2023
Q2
$1.01M Sell
12,411
-444
-3% -$35.4K 0.02% 230
2023
Q1
$1.05M Buy
+12,855
New +$918K 0.02% 224

Other funds holding GEHC

Welch & Forbes's GEHC Position: Q2 2026 in Review

Welch & Forbes reduced its GE HealthCare (GEHC) stake by 9.2% in Q2 2026, selling an estimated $63.7K and leaving 9,517 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #268.

Welch & Forbes first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.05M in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Welch & Forbes held 9,517 shares of GE HealthCare worth $609K as of Q2 2026.
  • Welch & Forbes sold 969 GE HealthCare shares in Q2 2026, an estimated $63.7K.
  • GE HealthCare made up 0.01% of Welch & Forbes's portfolio in Q2 2026, its #268 holding.
  • Welch & Forbes first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Welch & Forbes's GE HealthCare position peaked at $1.05M in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.